Isofol Medical AB (publ)

SSE:ISOFOL.ST

0.616 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Revenue 000-0.0010.3610.7211.8562.9074.0274.0064.7055.1547.3335.21518.6818.43900000000000.0210.0650.0650.0760.0810.090.1390.1980
Cost of Revenue 0.0019.6740.0010.110.34715.02727.3437.23460.39953.5367.55557.37151.75749.34559.86745.88742.53351.24943.68239.75200000040.63817.90811.82613.27222.0038.83710.82314.9360
Gross Profit -0.001-9.674-0.001-0.1110.014-14.306-25.484-34.327-56.372-49.524-62.85-52.217-44.424-44.13-41.187-27.448-42.533-51.249-43.682-39.752000000-40.617-17.843-11.761-13.196-21.922-8.747-10.684-14.7380
Gross Profit Ratio 0001110.039-19.842-13.731-11.808-13.999-12.362-13.358-10.131-6.058-8.462-2.205-1.4890000000000-1,934.143-274.508-180.938-173.632-270.642-97.189-76.863-74.4340
Reseach & Development Expenses 00000000000000000000000000000000000
General & Administrative Expenses 0000000051.5347.26358.16749.35245.60343.58959.86745.88742.53351.24943.68239.75229.92124.7822.32313.82216.0219.951017.90811.826000000
Selling & Marketing Expenses 00000000000000000000000000000000000
SG&A 12.1211.52710.1377.4719.4592.90412.2058.20551.5347.26358.16749.35245.60343.58959.86745.88742.53351.24943.68239.75229.92124.7822.32313.82216.0219.95166.36217.90811.82608.5330000
Other Expenses -0.011000015.11827.43738.0859.6516.2889.3968.0076.3946.3638.5414.0524.7036.78311.7895.8996.3935.596.5723.0764.10823.92725.61119.90313.71313.27230.5448.74710.684010.501
Operating Expenses 12.1219.68110.1377.5449.54215.11827.43738.08561.18153.55167.56357.35951.99749.95268.40849.93947.23658.03255.47145.65136.31430.3728.89516.89820.12823.92725.61119.90313.71313.27230.5448.74710.684010.501
Operating Income -12.122-9.674-10.138-7.543-9.542-14.395-25.581-35.178-57.155-49.545-62.858-52.205-44.664-44.738-49.726-31.5-47.236-58.032-55.471-45.651-36.314-30.37-28.895-16.898-20.128-23.927-25.611-19.903-13.713-13.196-30.544-8.747-10.684-14.738-10.501
Operating Income Ratio 0007,543-26.432-19.965-13.783-12.101-14.193-12.368-13.36-10.129-6.091-8.579-2.662-1.7080000000000-1,219.571-306.2-210.969-173.632-377.086-97.189-76.863-74.4340
Total Other Income Expenses Net 1.0771.1921.2551.2832.035-0.1120.2462.6653.1221.6712.6891.179-0.732.075-4.931.4-1.0832.117-2.4433.71.5613.404-0.091-0.4033.1794.04-0.0950.648-0.001000-0.001-0.0010
Income Before Tax -11.045-8.482-8.883-6.26-7.507-14.395-25.335-32.513-54.033-47.874-61.17-51.026-45.394-42.662-54.658-30.1-48.319-55.915-57.914-41.951-34.753-26.966-28.986-17.301-16.949-19.887-25.706-19.255-13.714-13.196-30.544-8.747-10.685-14.739-10.501
Income Before Tax Ratio 0006,260-20.795-19.965-13.65-11.184-13.418-11.951-13.001-9.9-6.19-8.181-2.926-1.6320000000000-1,224.095-296.231-210.985-173.632-377.086-97.189-76.871-74.4390
Income Tax Expense 0-0.042-0.0431.2832.041-0.002-0.246-2.665-3.122-3.343-2.6890-0.7100.0010006.40401.6130.0457.362-0.383.1943.422000.197-0.28300-0.03300
Net Income -11.045-8.482-8.883-6.26-7.507-14.393-25.089-29.848-50.911-44.531-61.17-51.026-45.394-42.662-54.659-30.1-48.319-55.915-57.914-41.951-34.753-26.966-28.986-17.301-16.949-19.887-25.706-19.255-13.714-13.196-30.544-8.747-10.685-14.739-10.501
Net Income Ratio 0006,260-20.795-19.963-13.518-10.268-12.642-11.116-13.001-9.9-6.19-8.181-2.926-1.6320000000000-1,224.095-296.231-210.985-173.632-377.086-97.189-76.871-74.4390
EPS -0.068-0.053-0.055-0.039-0.047-0.089-0.16-0.18-0.32-0.28-0.38-0.32-0.48-0.4-0.52-0.29-1.04-1.38-1.03-1.03-0.86-0.48-0.52-0.31-0.3-0.36-0.53-0.41-0.24-0.45-1.08-0.31-0.36-0.96-0.36
EPS Diluted -0.068-0.053-0.055-0.039-0.047-0.089-0.16-0.18-0.32-0.28-0.38-0.32-0.48-0.4-0.52-0.29-1.04-1.38-1.03-1.03-0.86-0.48-0.51-0.31-0.3-0.36-0.53-0.41-0.24-0.45-1.08-0.31-0.36-0.96-0.36
EBITDA -12.121-9.673-10.137-6.15-7.154-13.993-24.906-32.081-53.623-49.144-58.078-51.806-44.975-44.337-51.633-31.049-46.79-57.596-48.652-45.259-34.316-30.008-21.493-17.239-16.895-23.927-25.577-19.866-13.713-13.196-30.507-8.714-10.684-14.709-10.391
EBITDA Ratio 0006,150-19.817-19.408-13.419-11.036-13.316-12.268-12.344-10.052-6.133-8.502-2.764-1.6840000000000-1,217.952-305.631-210.969-173.632-376.63-96.822-76.863-74.2880